Advertising Console

    Dr. Paul Janssen Award

    Repost
    MultiVu

    by MultiVu

    273
    58 views
    Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab)*, is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium. To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pauljanssenaward/38987/